Key facts
- TRILANTIC NORTH AMERICA is a private equity firm based in NEW YORK, NY with 2 tracked portfolio companies.
- Notable positions include Rarebreed Veterinary Partners, SOFIE.
- TRILANTIC NORTH AMERICA reports $38.5M in regulatory assets under management across 19 private funds, per its SEC Form ADV (2026-03).
Registered with the SEC
Form ADV · 2026-03 · CRD 152331- Regulatory AUM
- $38.5M
- Private fund assets
- $5.8B
- Private funds
- 19 · 19 private equity
- Staff
- 37
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as TRILANTIC CAPITAL MANAGEMENT L.P.).
Free account
See more of the book
- ·Watchlist + alerts for TRILANTIC NORTH AMERICA's activity
Create free account
No card required
Portfolio
2 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Rarebreed Veterinary Partners | — | ▮ | ▮ | ▮ |
| SOFIE | — | ▮ | ▮ | ▮ |
All 2 companies — valuations, dates and lead flags are a member feature | ||||
Frequently asked
- What companies does TRILANTIC NORTH AMERICA invest in?
- TRILANTIC NORTH AMERICA has 2 recorded portfolio companies, including Rarebreed Veterinary Partners, SOFIE.
- What is TRILANTIC NORTH AMERICA's AUM?
- TRILANTIC NORTH AMERICA manages approximately $38.5M in assets.